Medexus Announces Strongest Quarter in Company History with Fiscal Q2 2023 Revenue of US$27.7 Million, a 55% Increase Over Fiscal Q2 2022
Stock Information for Medexus Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.